Effects of Myofascial Release on Pain, Disability and Electromyography of Erector Spinae in Chronic Low Back Pain
CompletedNot applicableNCT01241071
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine whether myofascial release techniques are effective in the improvement of pain, disability and electromyography response of lumbar muscles in patients with chronic low back pain.
Study details
- Official title
- Effects of a Myofascial Release Protocol on Pain, Disability and Activation Pattern of Erector Spinae in Patients With Chronic Low Back Pain
- Conditions
- Low Back Pain
- Disability
- Motor Activity
- Range of Motion
- Interventions
- Other: myofascial treatment
- Other: Placebo
- Sponsor
- Cardenal Herrera University
- Collaborators
- Hospital Arnau de Vilanova
- Start date
- 2011-01
- Primary completion
- 2012-12
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * low back pain for more than 3 months Exclusion Criteria: * vertebra fractures * systemic disease (spondylitis, neoplasia, infectious, vascular, endocrine or metabolic disorders) * spinal surgery * advanced lumbar instability * osteoporosis (in advanced stage) * degenerative articular disease * acute soft tissue inflammation * rheumatoid arthritis * osteomyelitis * neuromuscular disease * lower limb musculoskeletal injuries * radiculopathy * cauda equine syndrome * myelopathy * stenosis * structural spine deformity (kyphoscoliosis...) * pregnancy * abundant menstruation * IUD carrier * mental disease * dermatologic disease * skin sensitivity * aneurysma * corticosteroids treatment * anticoagulant therapy * hypertension * diabetes * hemophilia * leucemia * rejection to manual contact
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01241071